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Human intestinal epithelial organoids are an emerging tool, both in research and in a clinical 
environment.  Due to their structural and functional similarity to physical organs, human 
intestinal organoids (HIOs) are utilised to model the complexities of human disease pathology 
including colorectal cancer and inflammatory bowel disease, of which for both, the site of 
initiation is the colonic epithelium. Current culture methods for HIOs are dependent on 
growth in an ill-defined, tumour-derived extracellular matrix (ECM), that is of animal origin; 
which has confounded the use of organoids in a translational and regenerative medicine 
capacity. There is the therefore, growing appreciation for the use of chemically defined, 
synthetic hydrogels which have been optimised to support the growth and development of 
HIOs. In this study, we demonstrate the ability of a synthetic, fully defined hydrogel, based on 
the reaction between four-armed, thiol and maleimide-terminated poly(ethylene glycol) 
(PEG) macromers to support the three-dimensional growth and expansion of HIOs. We 
explore the effects of altered hydrogel parameters such as matrix stiffness and porosity on 
organoid growth and demonstrate the potential of functionalising inert PEG hydrogels, 
through assessing organoid growth and survival in response to the inclusion of degradable 
peptides and human recombinant ECM proteins in the matrix. Our research shows the 
potential of PEG-based hydrogels to overcome the limitations of current organoid culture 
systems and suggests a foundation by which PEG hydrogels can be further optimised to 
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1. Introduction  
 
1.1 Colonic epithelial organisation  
 
The large intestine, also known as colon, forms part of the human gastrointestinal tract and 
has key roles in nutrient absorption and digestion. To protect the systemic circulation of the 
host from the often-hostile luminal contents of the gut, such as exogenous bacteria, fungi and 
viruses; the intestine is lined with a monolayer of polarised columnar epithelial cells known 
as the intestinal epithelium (Okumura and Takeda, 2017). This colonic epithelium contains a 
number of specialised cell types as seen in Fig 1, such as enterocytes (colonocytes) necessary 
for water absorption, and goblet cells, which are responsible for secretion of mucus, and 
other proteins that are associated with the formation of the protective barrier (Allaire et al., 
2018). Both the protective and absorptive functions of the gut are dependent on maintaining 
an intact epithelium. Therefore the colonic epithelium is capable of rapid tissue renewal, with 
homeostasis being maintained through the shedding of differentiated epithelial cells, and the 
rapid, continuous proliferation and migration of undifferentiated cells to replenish lost cells, 
or repair tissue following injury (Humphries and Wright, 2008). The intestinal epithelium is 
highly dynamic, with the entire epithelial lining being replenished every 5 to 7 days (van der 














Figure 1. Schematic diagram showing the organisation and various specialised cell types of 
the large intestinal epithelium. (Allaire et al., 2018)  
1.2 The Intestinal Stem Cell Niche  
The process of epithelial cell renewal is dependent on a subset of adult intestinal stem cells 
(ISC’s) which give rise to progenitor cells, that are capable of differentiation into all cell types 
required for healthy gut function (Chee, Virshup and Madan, 2015). These stem cells are 
housed in specialised microenvironments which reside at the base of invaginations into the 
underlying mucosa, known as crypts of Lieberkühn. These crypts represent the single, unitary 
structure of self-renewal; where the base of each crypt serves as the intestinal stem cell niche, 
housing long-lived stem cells in a relatively sterile environment (Humphries and Wright, 
2008). Here, ISC exposure to bacterial toxins and metabolites, dietary mutagens, 
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immunological cytokines and oxidative stress is reduced, minimising the risk of accumulating 
molecular damage (Chee, Virshup and Madan, 2015). ISCs at the crypt base fuel the constant 
replenishment of shed gut epithelial cells, whose brief residency in the gut also aid in reducing 
the probability that any singular epithelial cell will accumulate the complement of genetic 
mutations required for tumour initiation (Humphries and Wright, 2008).  
1.3 Role of Wnt Signals Within Intestinal Crypts  
Wnt signalling was found to be a driving force behind physiological crypt proliferation, 
through its dysregulation being the primary driver of colorectal cancer (Cernat et al., 2014). 
Overall, around 80% of bowel cancer cases are fuelled by mutated APC genes (CRUK, 2012) 
which results in the failure of the APC destruction complex to function, and subsequent build-
up of β-catenin, the key effector of Wnt signalling (van der Flier and Clevers, 2009) (Fig 2). 
Accumulation of β-catenin was found to induce transcriptional activation of Tcf4 target genes 
resulting in uncontrollable cell proliferation (van der Flier and Clevers, 2009). This, coupled 
with evidence that Tcf4 knockout mice lack proliferative crypts (Korinek et al., 1998), 
highlights the importance of Wnt signals in regulating proliferation within the crypt and 









Figure 2. Schematic diagram of the Wnt signalling pathway in active (right) and inactive (Left) 
state (Zhan, Rindtorff and Boutros, 2017). 
1.4 LGR5 – An Intestinal Stem Cell Marker 
Early microarray experiments on the Wnt-pathway-controlled genes, expressed in both colon 
cancers and healthy crypts, unveiled the prominence of the Leucine-rich, repeat-containing, 
G-protein coupled receptor 5 (LGR5) gene. LGR5 encodes for a receptor of Wnt pathway 
agonists, R-spondins (Barker et al., 2007). R-spondin signalling works to enhance Wnt signals 
in intestinal crypts by neutralising transmembrane ligases, that would otherwise remove Wnt 
receptors from the cell surface (de Lau et al., 2014), and is therefore a prominent driver of 
crypt cell renewal. Using an inducible Cre knock in allele and the Rosa26 lacZ reporter strain, 
lineage tracing experiments were performed in mice and demonstrated exclusive LGR5 
expression in cycling crypt base columnar cells (CBC), which were capable of generating all 




identification of the intestinal stem cell and demonstrated the significance of LGR5 as an 
intestinal stem cell marker.  
1.5 Human Intestinal Organoid Culture  
It was later discovered that single LGR5+ intestinal stem cells could be expanded in culture to 
generate 3D gut epithelium cultures, otherwise known as organoids (Fig 3) (Sato et al., 2009). 
These organoids maintain the LGR5(+) stem cell hierarchy, are self-organising and do not 
require an epithelial cellular niche. Organoids can be cultured indefinitely in epithelial growth 
factor (EGF), Noggin and R-spondin enriched conditions, supported by a 3D matrix, and retain 
the hallmarks of the in vivo intestinal epithelium (Sato et al., 2013), therefore stem-cell-
derived organoids have therefore become promising models of disease development, 
potential drug screening platforms and a potential source of transplantable tissue (Rossi, 







Figure 3. Schematic and brightfield images highlight the stages of organoid growth and 
development. Budding structures are highlighted (red rectangle) and demonstrate crypt-like 




1.6 Organoids as Models of Development  
Organoids have proven vital models of development, homeostasis and regeneration, in 
particular, mouse derived small intestinal epithelial organoids were used to demonstrate how 
LGR5+ mouse ISCs are dependent on Wnt signals from neighbouring Paneth cells in the small 
intestine (Sato et al., 2011). Paneth cells were seen to express essential signals for stem cell 
maintenance including  EGF, TGFα, Wnt3 and the Notch-ligand Dll4, and their co-culture 
alongside ISCs greatly improved organoid formation (Sato et al., 2011). This work revolving 
around an organoid model, in addition to other observations, helped indicate a model by 
which the confinement of Paneth cells to the base of small intestinal crypts defines separation 
between ISC self-renewal and differentiation in the small intestine.  
1.7 Organoids as Models of Disease  
Organoids are also capable of mimicking disease pathology at an organ level, and therefore 
prove advantageous for disease modelling, drug discovery and personalised medicine, when 
compared to traditional single cell type cultures. (Rossi, Manfrin and Lutolf, 2018). Organoid-
based disease models have already been developed for several disease types and have 
provided evidence that organoids are capable of recapitulating well known pathological 
features. An example of this is the development of human gastric organoids, that when 
injected with Helicobacter pylori bacteria, successfully reproduce the typical signs of the 
infection, including species-specific features of human gastric pathology, i.e. the progression 
to ulceration and cancer, which make animal models unsuitable for these studies (McCracken 
et al., 2014; Bartfeld et al., 2015).  The usage of organoids in mimicking disease pathology has 
led to studies exploiting this for drug testing and screening applications (Fig 4). Patient derived 
intestinal organoids have laid the foundation for organoid research in personalised medicine 
by being successfully used to screen for drugs to treat cystic fibrosis (CF), a genetic disease 
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caused by mutations in the CFTR gene (Jane C Davies, 2007). Intestinal organoids were derived 
from a patient with a rare CFTR mutation, with no known treatment, and a standardised 
functional test by which cAMP-induced organoid swelling indicated restored CFTR 
functionality, was used to screen existing known CF drugs, allowing the patient to access 
treatment (Saini, 2016).  
1.8 Intestinal Organoids Biobanks  
An emerging application for organoids is the generation of organoid biobanks for different 
pathologies, that will be capable of acting as a powerful screening platform covering a large 
amount of genetic variance from the general population (Rossi, Manfrin and Lutolf, 2018) (Fig 
4). Current work in the Williams laboratory has involved the generation of an intestinal 
organoid biobank, establishing organoid cultures from the healthy and diseased tissue of 
colorectal cancer patients as well as sufferers of IBD. This has allowed the disease process to 
be studied in native human tissue and will facilitate the discovery of both preventative and 













Figure 4. Schematic diagram showing key applications of organoids in disease modelling. The 
use of organoids in a research environment is indicated through the study of disease 
mechanisms and the development of drug screening platforms, whilst the clinical applications 
are highlighted in the form of personalised medicine (Rossi, Manfrin and Lutolf, 2018) 
1.9 Current Organoid Culture Methods  
Organoids have the potential to be a powerful tool for research and at a clinical level, it is of 
the utmost importance that their 3D culture conditions allow for highly reproducible 
generation of organoids, with a high level of functional and structural similarity to physical 
organs. As laminin (α1 and α2) is enriched in the physiological crypt base Currently, routine , 
3D culture methods have relied on the commercially available, laminin-rich hydrogel 
matrixces knownsuch as Matrigel, a basement membrane-like gel secreted by mouse sarcoma 
cells (Sato and Clevers, 2013). Proteomic analysis of Matrigel revealed its composition of a 
complex assortment of 1851 unique proteins, glycoproteins and proteoglycans, primarily 
consisting of ECM proteins such as laminin, collagen type IV and enactin (Hughes, Postovit 
and Lajoie, 2010). In addition several growth factors were detected in varying quantities 
including epidermal growth factor, fibroblast growth factor, transforming growth factor beta 
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and others (Hughes, Postovit and Lajoie, 2010). Although effective in promoting cell growth 
and self-organisation, Matrigel is limited in its ability to direct organoid morphogenesis and 
offers no control over the 3D self-organisation process (Hughes, Postovit and Lajoie, 2010). 
This is owing to its poorly defined chemical composition, containing largely variable 
concentrations of growth factors and proteins from batch-to-batch, as well as its inability to 
be chemically or physically modified, preventing specific tailoring of biophysical or 
biochemical matrix properties for intestinal organoids (Gjorevski et al., 2016). As both 
chemical and mechanical/physical cues from the ECM drive organogenesis, it is important to 
be able to modulate matrix cues such as mechanical stiffness, adhesive ligand presentation 
and degradability in order to model the complex interplay between cell behaviour and the 
physical environment that is demonstrated in the intestinal epithelium (Raeber, Lutolf and 
Hubbell, 2005). Furthermore, Matrigel is an animal derived product which confounds its use 
in a clinical environment due to the risk of immunogen and pathogen transfer (Gjorevski et 
al., 2016). 
1.10 ECM and the Intestinal Stem Cell Niche  
In the human gut epithelium, crypts are formed by epithelial invaginations into the 
extracellular matrix (ECM) which is supported by stromal cells (Meran, Baulies and Li, 2017). 
The intestinal stem cells, which are located at the crypt base, are maintained by their 
surrounding niche for regulation of both differentiation and self-renewal under homeostasis 
(van der Flier and Clevers, 2009).  The ECM provides the physical niche, and is comprised of a 
network of fibrous structural proteins including proteoglycans (PGs) and glycoproteins which 
act as a physical scaffold, maintaining a 3D morphology (Meran, Baulies and Li, 2017). The ISC 
niche is also surrounded by other ECM components such as different laminin isoforms, 
collagens, glycosaminoglycans and fibronectins (Czerwinski and Spence, 2017) that provide 
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structural support, as well as influencing stem cell behaviour through mediation of instructive 
cell signalling (Vazin and Schaffer, 2010). For example 2 isoforms of the heterotrimeric ECM 
protein Laminin (α1 and α2) are enriched in the physiological crypt base (basal laminae) and 
have been seen to interact with ISCs via integrins – transmembrane heterodimeric receptors 
located on the cell surface that link the ECM with the intracellular cytoskeleton, mediating 
cell anchorage and mechanotransduction, as well as suggesting a potential role for integrin-
mediated signalling in ISC regulation (Meran, Baulies and Li, 2017). In addition to the physical 
niche, cells embedded into the ECM form the cellular niche (Fig 5),  secreting a range of matrix 
components and growth factors which are capable of altering ISC proliferation and 
differentiation (Chee, Virshup and Madan, 2015). The ECM is therefore vital to maintain the 
ISC niche, and both physical and cellular elements of the ECM are known to regulate both 
proliferation and differentiation through several pathways including the Wnt/β-catenin 
cascade, Notch signalling, TGF- β/BMP and Hedgehog pathways (Meran, Baulies and Li, 2017). 
In addition, the ECM is suggested to function as a reservoir for growth factors, through the 
ability of heparin sulfate proteoglycan, a common component of many ECM PGs, to bind 
growth factors such as FGF and VEGF allowing for the establishment of morphogen gradients 
– which plays a vital role in patterning, growth and development (Hynes, 2009). These growth 
factors may also be released during degradation of the ECM, highlighting how proteolytic 
remodelling of the surrounding ECM by secreted matrix metalloproteinases (MMPs) may 









Figure 5. Schematic diagram of the interaction between intestinal epithelial crypts (the 
intestinal stem cell niche) and the surrounding microenvironment. Detailed on the left is the 
interaction between the highly structured ECM which is mediated through integrins, whilst 
the right-hand side details interaction of the crypt base with the cellular niche. 
Communication between the ECM and cellular niche is achieved via the highlighted signalling 
pathways (Meran, Baulies and Li, 2017). 
1.11 ECM and Organoid development  
Several studies have revealed the importance of choosing an appropriate ECM or ECM-mimic 
when developing a 3D matrix for organoid culture. Mouse-derived small intestinal organoids 




budding cysts, while in contrast, mouse small intestinal organoids grown in floating collagen 
gel rings formed a seemingly continuous macroscopic tube, with budding crypts along the 
tube axis, highlighting that an alteration of the ECM constituents has a drastic effect on 
organoid formation and organisation (Sachs et al., 2017). Fibrin based hydrogels have also 
demonstrated that organoid formation is dependent on matrix properties such as mechanical 
stiffness and availability of an RGD motif, a tripeptide originally identified as the amino acid 
sequence within the ECM protein fibronectin that mediates cell attachment (Ruoslahti, 1996). 
This study using a fibrin-based gel identified that increasing matrix stiffness whilst decreasing 
RGD availability reduced organoid formation. In addition, supplementing the gel with laminin, 
a major component of Matrigel, led to organoid yields in the fibrin/laminin gel that were 
comparable to Matrigel (Broguiere et al., 2018). 
1.12 Chemically Defined, Synthetic Hydrogels and Organoid Culture  
As the growth of LGR5+ stem cells into self-organising organoids is enhanced by a 3D 
extracellular matrix like-gel, there is a requirement for a synthetic, chemically defined 
hydrogel, whose chemical and physical properties are subject to manipulation in order to fully 
optimise the growth and maturation of organoids embedded into the gel. By controlling the 
distribution of signalling molecules and ECM proteins, as well as manipulating the gels’ 
mechanical properties such as porosity and stiffness, there is the potential for organoid 
cultures within an optimised synthetic gel to reproducibly surpass the growth and self-
organising potential achieved in Matrigel. A class of synthetic biomaterials that have been of 
great research interest are hydrogels. Hydrogels can be formed from synthetic, or naturally 
occurring polymers that closely mimic the natural environment of cells, through their 
susceptibility to physical and chemical manipulation (Caliari and Burdick, 2016). They possess 
a high-water content and can form 3D complexes around viable cells, allowing for three-
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dimensional growth and signalling. Hydrogels have several characterisable properties 
including mechanics such as crosslinking density, swelling, mesh size and degradation, all of 
which influence the utility of the gel for cell culture applications (Caliari and Burdick, 2016). 
For example, matrix stiffness can influence stem cell differentiation through the activation of 
cellular mechanotransduction pathways, i.e. the activation of biochemical signalling pathways 
from the mechanical information of the microenvironment (Ingber, 2006). It is therefore 
necessary to consider the properties of each hydrogel system, in order to select a gel that is 
optimal for intestinal organoid expansion. 
1.13 PEG Hydrogels and Organoid Culture  
Polyethylene glycol (PEG) is a readily available hydrophilic polymer, that when crosslinked 
into hydrogel networks, possess a high-water content, making them suitable to emulate soft 
tissues (Leach, 2011).  A major advantage of PEG based hydrogels is their relative inertness 
and cytocompatibility, as evidenced by their failure to initiate an immune response in the cells 
they encounter (Mäder, 2011). Often referred to as a ‘blank slate material’ PEGs are amenable 
to functionalisation with user-defined crosslinking groups, allowing for control over the 
crosslinking properties of the gel (Caliari and Burdick, 2016). This is due to the basic structure 
of PEG, which is capped with hydroxyl end groups, allowing the polymer to partake in a variety 
of chemical reactions (Zhu, 2010). Raeber, Lutolf and Hubbel pioneered the use of PEGs 
functionalised with vinyl sulfone (VS) in hydrogel preparations, as PEG-VS reacts specifically 
with free thiols, such as peptides terminated with cysteine residues (Raeber, Lutolf and 
Hubbell, 2005). Cells and proteins within the gel rarely possess exposed cysteine residues on 
their surface and thus peptides can be incorporated that render the gel with biological 
activity, such as adding cell adhesive domains from ECM proteins and peptide substrates for 
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matrix metalloproteinase degradation, allowing cells to mimic attachment and migration 
through the ECM (Leach, 2011).  
A pivotal study identified that a chemically defined, synthetic PEG based hydrogel could be 
used as a suitable Matrigel replacement to culture intestinal epithelial organoids (Gjorevski 
et al., 2016). PEG as a biomaterial offers a highly amenable matrix that can be independently 
modulated to alter variables including matrix stiffness, degradability and adhesiveness, in 
order to assess their effects on ISC proliferation, organoid formation and cellular 
differentiation. This work observed that a mechanically dynamic matrix was required 
providing an initial stiffness that favoured stem cell expansion, but was hydrolytically active 
and therefore able to soften, alleviating mechanical forces and favouring cell differentiation 
(Gjorevski et al., 2016). Hydrogel mechanical properties can be characterised using a 
technique known as rheology, in which a small amount of a sample is subject to rotational 
compressive forces, probing the stress-strain relationship of the gel and obtaining the 
samples equilibrium shear modulus (Zuidema et al., 2014). This information can be used to 
reveal structural properties such as degree of crosslinking and mechanical stiffness. The 
hydrogels generated by Gjorevski et al., were optimised using a mouse intestinal epithelial 
organoid model, however. eExperiments have also demonstrated that PEG hydrogels could 
also include functionalisation with human-derived intestinal ECM components, as well as 
investigating how spatiotemporal control of mechanical cues and signalling gradients can 
enable hydrogels to better mimic the structure of the native human intestine (Wang et al., 
2017). 
1.14 Objectives  
In this study we explore the encapsulation, growth and functionality of intestinal organoids 
in synthetic PEG based hydrogels, based on the reaction between two functionalised PEGs, 
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PEG-thiol (SH) and PEG-Maleimide (MAL) (Fig 6). Maleimide, like VS, reacts readily with free 
thiols under physiological conditions allowing for the formation of a high-water content 
hydrogel, with a rapid gelation time and in conditions optimal for organoid survival (Jansen et 
al., 2018). PEG-MAL was seen to exhibit faster reaction kinetics, and allow for the generation 
of hydrogels of lower polymer weight and across a larger range of Youngs moduli, than PEG-
VS (Phelps et al., 2012). Using a PEG hydrogel system as a foundation provides a 
platformallows for further modification. The interaction between thiol and maleimide 
functional groups provide chemical cross-linking with tuneable reaction kinetics, whilst  
through varying the PEG molecular weight (PEG chain length) and overall % PEG content of 
the gel alters the physical interactions caused by entanglement of the PEG chains. PEG 
hydrogels , therefore provide tuneablealtering hydrogel characteristics including, stiffness, 
mesh size and porosity, as well as enabling the inclusion of adhesive ligands and degradable 
peptides. 
 
Figure 6. Chemical formula of PEG thiol and maleimide respectively (JenKem, 2019) 
In this study we aim to  
I. Engineer a synthetic, fully defined and optimised hydrogel, inspired by the colonic 
crypt ECM, that supports the growth of human intestinal organoids.  
4 ARM PEG MAL (Maleimide) 
PEG chain  
Reactive functional group 
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II. Characterise organoid growth, cell proliferation and stem cell biology of intestinal 




2. Materials and methods  
2.1 Cell Culture  
The Adult equine GFP+ tenocyte cell line was kindly donated by Dr. Deborah Guest (Animal 
Health Trust, Newmarket, UK). The cells were used in passage 8 for the experiments, and 
grown as monolayers in DMEM, GlutaMAX™ (catalogue number: 10566016, ThermoFisher 
Scientific), supplemented with Fetal Bovine Serum (FBS) and Penicillin-Streptomycin (P-strep). 
Both cell lines were expanded in 75 cm2 Nunc™EasYFlasks™ incubated at 37⁰C, 5% CO2, until 
80% cell confluence was achieved, refreshing 100% of the media every 4 to 5 days. For the 
cell seeding, cell monolayers were washed with PBS before detaching the cells using Trypsin-
EDTA solution (CN: 25300054, ThermoFisher Scientific) for approximately 3 minutes at 37⁰C. 
The trypsin was neutralised via the addition of fresh media and the cells were centrifuged 
before counting to remove residual trypsin.  
2.2 Cell Encapsulation 
Under sterile conditions degassed PBS 1X containing 4mM EA, 5mM EDTA was passed through 
a 0.22µM filter and 100 µL added independently to 4ARM PEG Thiol (JenKem tech. USA, SKU: 
A7008-1) and 4ARM PEG Maleimide (JenKem tech. USA, SKU: A7018-1) to make 4% w/v PEG 
solutions. A concentrated cell suspension of 5000 GFP+ tenocytes were added to the PEG-
thiol solution and following gentle mixing, a 10 µL droplet was plated. An equivalent volume 
of PEG-Maleimide was then added to the cell-containing PEG-thiol and mixed rapidly with the 
pipette to ensure an even distribution of maleimide before gelation occurred. The droplets 
were left to polymerise at room temperature for 5 to 10 minutes before removing the gel 
using a sterile metal spatula and placing each droplet into individual wells of a 48 well plate 
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containing 1 mL of DMEM. The gels were incubated in a humidified atmosphere at 37 ⁰C, 5% 
CO2. 
2.3 Fluorescent Imaging to visualise GFP+ Tenocytes 
After 24 hours, 3 gels were removed from DMEM and placed into a fresh 48-well plate 
containing 1 mL of PBS for imaging. The remaining gels were maintained at 37 ⁰C, 5% CO2 for 
7 days before imaging. Imaging was performed using a Zeiss Axiovert 200M microscope using 
AxioVision software. Images were obtained using a 20 X magnification Plan-Neofluar (0.5 NA) 
objective and a Zeiss AxioCam HRm CCD camera. Fluorescence was excited at 494-517 nm 
(GFP) and merged images were created using Image J software.   
2.4 Live and Dead Viability Assay  
Human colonic organoids were cultured in a 24-well culture plate (Nunc™ Surface, 
ThermoFisher scientific) in 10%, 10K 4arm PEG gels either unaltered or containing 10% LAM 
111, 121, 511, 521, 511 and 521 together, or all 4 laminins in combination. After 7 days, the 
organoids were washed with HBS and freshly prepared Calcein AM-Ethidium homodimer-1 
(ThermoFisher) was added to the organoids according to the manufacturer guidelines. 
Imaging was performed using an Inverted Nikon microscope and Hamatsu CCD Camera. 
Fluorescence was excited at 494-517 nm (calcein, green) or 528-617 nm (Ethidium 







2.5 Tissue sample collection  
Biopsy samples of healthy colonic epithelial tissue were obtained from patients at the Norfolk 
& Norwich University Hospital (NNUH) that had undergone exploratory colonoscopy 
procedures. The samples were collected by members of the Williams laboratory, with 
consent, and in compliance with the Human Tissue Act of 2004 and NHS research and 
development approval. Biopsy samples were kept cool within a sealed container and 
transported to the laboratory via a member of the Williams Lab.  
2.6 Human Colonic Crypt isolation  
Human colonic crypts were isolated from fresh biopsy samples obtained from the NNUH 
following a protocol outlined by Parris and Williams (Parris and Williams, 2015), whereby 
whole crypts are liberated from the mucosal tissue into fresh crypt isolation solution. A 100 
µL sample of isolated crypt suspension is added to 400 µL of chilled Matrigel®, and mixed 
before dispensing 20 µL onto coverslips and placing at 37 ⁰C for 15 minutes to allow 
polymerisation of the Matrigel. Once polymerised, the wells were flooded with 400 µL of 
human colonic crypt culture medium (hCCCM) and the plates returned to the incubator.  
2.7 Human Colonic Organoids Culture  
Human colonic organoids were obtained by members of the Williams lab after the passage of 
colonic crypts grown for 7 days. The samples were detached from the bottom of the plate by 
scratching the surface and mechanically dissociated into smaller fragments using a pipette. 
The suspension containing the crypt fragments was transferred into centrifuge tubes and 
pelleted at 40C. The supernatant containing cell debris and Matrigel leftovers was aspirated 
and then fresh media was added, and the crypt fragments resuspended. The final pellet was 
resuspended into a PEG-SH solution, before plating a 20 µL droplet. An equivalent volume of 
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PEG-MAL was then added, mixed rapidly and left to polymerise, before flooding the organoids 
with human colonic crypt culture media (hCCCM). Organoids were cultured at 370C and 5% 
CO2, fed every 3 days and passaged every 5 to 7 days. 
2.8 Hydrogel Preparation 
Hydrogels were prepared using  thiol-ene chemistry which has been utilised to generate PEG 
hydrogels for a range of applications (Toepke et al., 2013). Thiol (SH) and Maleimide (MAL) 
functionalised 4-arm PEGs were purchased in various molecular weights (5K, 10K, 20K and 
40K) from JenKem Tech. USA.  Both SH and MAL functionalised PEGs of the desired molecular 
weight were independently dissolved in filtered PBS 1X containing 5 mM EDTA, degassed with 
N2(g), to achieve precursor solutions of a desired w/v. Following a brief vortex, PEG precursor 
solutions were kept on ice, before a concentrated organoid suspension was added to the PEG-
SH and after gentle mixing 20 µL of PEG-SH was plated. An equivalent volume of PEG-MAL 
solution was then added to the PEG-SH to generate hydrogel networks of a desired final PEG 
content, where the stochiometric ratio of SH:MAL was 1:1. PEG SH/MAL hydrogels polymerise 
rapidly under physiological conditions, after 1 minute each well was flooded with 400 µL of 
hCCCM. The final PEG w/v of the hydrogels used range from 5% to 10%.  
2.9 Hydrogel Optimisation  
Corning® Matrigel® Basement Membrane Matrix (CN: 356232), VPM peptide 
(GCRDVPMSMRGGDRCG) Lifetein (CN: LT255422) and human recombinant Laminins (LAM) 
111, 121, 511 and 521 (BioLamina) were incorporated into the hydrogel backbone by mixing 
independently with the PEG-SH suspension at the relevant concentrations. Matrigel was 
incorporated at 2.5, 5 and 10% concentrations, VPM at 2:1 and 1:1 PEG: peptide ratios and 




2.10 Assessment of Organoid Growth  
Organoid growth and morphology were monitored in real time by placing a multi-well plate 
into a climate-controlled chamber (5% CO2, 37⁰C) located on the stage of an inverted 
microscope. DIC illumination was established with a x10 objective and whole well images 
were obtained. Images were captured every other day over the period of 7 days.  Organoid 
health and morphology were assessed visually and for living organoids, the size was 
determined using the Nikon, NIS-elements software to trace the circumference, obtaining a 
value of cross-sectional area (CSA). Healthy organoids were monitored over the 7-day 
duration and their CSA’s were measured on alternate days. Organoids were stratified into two 
groups based on starting CSA and normalised growth was reported as organoid growth in 
relation to starting size.  
2.11 Assessment of Cell proliferation  
Human colonic organoids were cultured in 10% PEG or 10% PEG + LN511,LN521 on glass 
coverslips in hCCCM for 3 days before EdU was added to the media at a concentration on 10 
µM, for a duration of 3 hours. Following labelling, organoids were fixed with 4% PFA for 1 
hour at room temperature. Post fixation, organoids were washed with PBS before a 13-
minute incubation at room temperature with NH4Cl2 and 2 subsequent PBS washes. The fixed 
organoids were then washed with 1% SDS, followed by several PBS washes. The organoids 
were then incubated, whilst covered, at room temperature for 30 minutes in the presence of 
1% Triton X-100.  The EdU reaction buffer was prepared according to The Click-iT EdU Cell 
Proliferation Kit (Invitrogen™) protocol, and following 2, 3% BSA washes, was added to the 
organoids, and incubated for 40 minutes, at room temperature in a reduced-light 
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environment. After 2 washes in 3% BSA the organoids were subjected to a standard 
immunocytochemistry protocol, including a 2-hour block of unspecific antibody binding via 
incubation in PBS containing 10% donkey serum, 1% BSA for 2 hours at room temperature. 
The primary antibodies E-Cadherin (goat) and Chromogranin A (mouse) were added at a 
concentration of 1:100 and stored at 4⁰C overnight. Following 2 washes with PBS, the 
secondary antibodies Donkey Anti-Goat IgG H&L (Alexa Fluor® 488) and Donkey Anti-mouse 
IgG H&L (Alexa Fluor® 594) were added at a concentration of 1:200 before a 2-hour incubation 
at 4⁰C. After 2 PBS washes, the coverslips were transferred to microscope slides using 
Vectasheild, Hoechst mounting media.  
2.12 RNA isolation  
RNA from freshly isolated colonic primary mucosa, freshly isolated crypts and human colonic 
organoids was isolated by the Williams  usinglab using the ReliaPrep ™ RNA Miniprep System 
(Promega) according to the manufacturer’s instructions. Total RNA concentration and purity 
was then measured using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher 
Scientific). 
2.13 Generation of DNA and RNA biobank 
The Williams lab A biobank was generated a Biobank containing the DNA and RNA from 
primary isolated colonic mucosa, crypts and colonic organoids of matching patients. Colonic 
crypt and isolated mucosa samples were obtained after a colonic crypt isolation. Colonic 
crypts were cultured and propagated into organoids and the DNA and RNA were isolated 
approximately after the 4th passage. The isolation of DNA and RNA was performed using the 
ReliaPrep ™ DNA Miniprep System (Promega) and ReliaPrep ™ RNA Miniprep System 
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(Promega) according to the manufacturers’ instructions and the samples were stored at -200C 
and -800C respectively. 
 
2.14 DataStatistical analysis  
Organoid growth data is presented as overall mean organoid growth ratio ± SE for each gel 
where mean organoid growth <1 is indicative of cell death. The standard error of the mean is 
presented in order to predict how far the sample mean of the data is likely to be from the 
final organoid population mean. The variables of polymer densityconcentration/PEG 
molecular weight combination, Matrigel concentration, VPM ratio and laminin type were 
each analysed using the one-way ANOVA statistical test to indicate significant differences in 
organoid growth. Where one-way ANOVA tests indicated significant differences, Tukey’s 
multiple comparisons tests were performed allowing for selection of optimal organoid growth 
conditions. A comprehensive list of ANOVA p values and n numbers is compiled in 




3. Results  
3.1 Assessment of cell viability within a PEG-Hydrogel  
Encapsulating cells into a hydrogel matrix and maintaining their viability in culture post-
encapsulation presents several challenges. Preliminary investigations involved generating a 
spectra of PEG-derived hydrogels ranging from low to high polymer densitiesconcentrations. 
A simplified schematic of the reaction between SH and MAL functionalised macromers is 
presented (Fig. 7A). Low densityconcentration hydrogels failed to polymerise and would 
therefore not support three-dimensional growth, whilst high polymer 
densitiesconcentrations had an extremely short gelation time, preventing even distribution 
of PEG and the formation of homogenous hydrogel droplets. The un-workable nature of 
higher polymer densityconcentration hydrogels also confounds their use for cell 
encapsulation. As organoids are large, multicellular structures, that are responsive to 
mechanics of their surrounding environment and PEG hydrogels differ mechanically and 
biochemically to the normal matrix that organoids are cultured in, we opted to first assess the 
viability of single cells encapsulated in PEG. A GFP+ tenocyte cell line was utilised due to their 
ease of visualisation, additionally, tenocytes are mechanically sensitive and have a clearly 
defined morphology making them suitable for assessing whether PEG hydrogels support 
viability. GFP + tenocytes were encapsulated in a 10K molecular weight,  8, 8% w/v PEG 
hydrogel and were seen to be viable through visual observation only at both 24 hours and 7 
days post encapsulation (Fig 7). Although appearing visually viable, the tenocytes have 
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Figure 7. Encapsulation of GFP+ tenocytes in synthetic PEG hydrogel. GFP+ tenocytes were 
encapsulated in 4ARM, 10K PEG hydrogels of 8% total PEG content. (A) Schematic diagram 
highlighting the reaction mechanism between SH and MAL functionalised macromers (Jansen 
et al., 2018). Representative images of encapsulated cells at 24 hours (B) and 7 days (C) are 
presented. Each image is presented as separate GFP, brightfield (BF) and composite images 
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3.2 Selection of optimal PEG molecular weight   
Matrix stiffness, crosslinking density, mesh size and porosity are key characteristics that affect 
organoid growth and can be controlled by altering the PEG molecular weight, and final 
polymer densityconcentration of the hydrogel. As we observed prolonged viability of a 
mechanically sensitive cell type in a 10K PEG hydrogel of 8% w/v, we rationalised that PEG 
hydrogels, at the right mechanical stiffness and porosity, would support the viability of human 
intestinal organoids. In order to assess which molecular weight PEG best supported organoid 
growth, and at which % polymer densityconcentration, organoids were embedded into a 
series of PEG hydrogels of increasing polymer densityconcentration and increasing PEG 
molecular weight (Fig 8). Organoid growth was presented as mean ratio between final and 
starting cross sectional area, with values less than 1 indicating a loss of size and cell death. 
We observed that the 10K PEG provided the highest mean growth ratios, and among 
hydrogels produced with this MW PEG, the higher polymer densityconcentration gels (10 and 
8%) had significantly increased growth ratios for both small (P=0.001, P=0.003) and large 








































































Figure 8.  Assessment of human intestinal organoid growth in synthetic PEG hydrogels of 
varying PEG content (Gel w/v %) and differing PEG molecular weights (5K, 10K, 20K and 40K). 
(A) Brightfield images of human intestinal organoids grown over a 7-day period in hydrogels 
of the indicated PEG MW and final PEG content (%). Images were obtained at a 4X 
magnification, on alternate days. Scale bar is 100 µM. (B-C) Organoids were cultured in the 
relevant PEG hydrogel for 7 days and stratified into 2 groups based on starting cross sectional 
area (“small” organoids ≤ 15000 µm2, B and “large organoids > 15000 µm2, C).  Data is 
expressed as the overall mean organoid growth ratio ± SE for each gel where mean organoid 
growth <1 is indicative of cell death.  Statistical analysis one-way ANOVA with Tukey’s multiple 
comparison test was applied for displaying significant differences between gel w/v and 
organoid growth ratio. (D) Heat map visualisation of organoid growth factors within PEG 
based hydrogels of increasing w/v% and PEG Molecular weight. Organoid starting cross 

















3.3 Organoid growth in synthetic PEG can be improved via the inclusion of natural ECMM  
Although we fter establisheding organoid growth could be achieved in raw, unoptimised PEG, 
the overall growth achieved, in addition to the characteristic morphology of optimal organoid 
formation (lumen development and formation of new budding ‘crypt-like’ domains) was 
significantly reduced when compared with organoids routinely cultured in the Williams lab 
using Matrigel (data not shown). Organoids cultured in Matrigel alone have clear, pronounced 
lumens that expand greatly over the course of a 7-day culture, which is accompanied by the 
formation of new budding structures.  Iit was therefore important to assess whether organoid 
cultures in PEG could be improved by the inclusion of natural ECM components. Hybrid 
hydrogels were generated using the molecular weight PEG and final PEG concentration that 
best supported organoid growth in an unoptimized state. Low concentrations of natural ECM 
proteins in the form of Matrigel were incorporated into the PEG based hydrogels, and their 
growth over a 7-day period was monitored (Fig 9). For organoids grown in 10K 8% w/v PEG 
hybrid gels, the mean growth factor after 7 days was significantly higher in gels that contained 
10% Matrigel, than in the control (P= 0.017), this trend was mirrored in the 10% gel (P= 0.032), 
although the mean organoid growth ratio in 10% PEG +10% Matrigel was seen to be greater 
than that achieved with the 8% gel. The improved growth characteristics in 10% 10K PEG + 
10% Matrigel can be observed in the brightfield images, where there is a large increase in 












































































Figure 9. Effect of increasing Matrigel concentration on mean organoid growth in synthetic 
PEG hydrogel. (A-B) Brightfield whole well images of human intestinal organoid growth in 
synthetic PEG hydrogels of 8% (A) and 10% (B) gels with, and without (Control) Matrigel, over 
a 7-day duration at 4X magnification. Scale bar indicates 100 µM. Organoids were cultured in 
4-ARM, 10K PEG hydrogels of 8% (C) and 10% (D) w/v. Dashed line represents a baseline 
growth ratio of 1. Data is expressed as the overall mean organoid growth ratio ± SE for each 
gel.  Statistical analysis one-way ANOVA with Tukey’s multiple comparison test was applied 
for displaying significant differences between Matrigel concentration and mean organoid 







As matrix remodelling is important in regulating cell differentiation and maintaining stem cell 
niches, we aimed to assess the effect of rendering synthetic PEG hydrogels proteolytically 
degradable, on organoid growth. Organoids were encapsulated in 10K 10% PEG hydrogels, 
that included the matrix metalloproteinase sensitive peptide VPM (Fig 11). There were no 
significant differences in the mean growth factors of organoids with a large starting CSA in 
the control gels, and gels containing VPM at either ratio (P=0.391). For organoids with a 
smaller starting CSA, the mean growth factor after 7 days was seen to be significantly reduced 
in gels containing 1:1 ratios of VPM (1.33 ± 0.11), than in control gels (2.36 ± 0.20) or gels 
containing 2:1 ratios of PEG:VPM (1.95 ± 0.11) P <0.001 and P= 0.004 respectively. Live/Dead 













































































Figure 10. Effect of optimizing gel degradability on mean organoid growth. Human intestinal 
organoids were embedded in 4ARM, 10K PEG hydrogels with a total PEG content of 10%, 
containing either control, 2:1 or 1:1 ratios of VPM.  The organoids were maintained in culture 
and (A) whole well brightfield images were obtained on alternating days at 4X magnification. 




for organoids of small (solid colour) and large (striped colour) starting cross sectional areas. 
Data is expressed as the overall mean organoid growth ratio ± SE for each gel.  Statistical 
analysis one way ANOVA with Tukey’s multiple comparison test was applied for displaying 
significant differences between VPM concentration and mean organoid growth ratio. 
**P<0.01, ***P<0.001. (C) Live and dead cells were stained with Live/dead cytotoxicity kit on 
day 9 of organoid culture in optimised hydrogels. Live cells were stained with calcein AM 
(green), and dead cells were stained with ethidium homodimer-1 (red). Images were obtained 
at 20 X magnification. Scale bar is 100 µM. 
3.5 Optimising synthetic PEG hydrogels with human recombinant laminin 
As optimising hydrogel degradability in isolation offered no improvement to mean organoid 
growth (Fig 11), we investigated whether synthetic PEG hydrogels could be optimized to 
include human recombinant laminin proteins (a major constituent of Matrigel), rendering the 
hydrogel more physiological and improving mean organoid growth. RNA sequencing of 
human intestinal organoids  revealed organoids possess transcripts for a several laminin 
chains indicating the expression of laminin 111, 511 and 521. Using this data in combination 
with literature that identifies high expression of laminin 111, 121, 511 and 521 in Matrigel , 
(Hughes, Postovit and Lajoie, 2010), organoids were embedded in 4ARM 10K, 10% PEG 
hydrogels optimized with a single, or combination of biologically relevant laminin(s) (Fig 12). 
After 7 days the mean organoid growth in PEG gels optimized with a combination of laminin 
511 and 521, were seen to display increased mean organoid growth when compared to the 
control (P=0.006). There were also significant differences in mean organoid growth between 
gels containing individual laminins, including an increased organoid growth ratio in organoids 
encapsulated in PEG optimized with laminin 111, however these were not seen to differ 
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significantly from the control. Interestingly, in gels optimized with all 4 recombinant laminin 
proteins, mean organoid growth was seen to be significantly reduced when compared to un-
optimized, control gels (P<0.001) as well as all gels that received either a single, or 
combination of laminin(s) (P<0.001). An assessment of cell proliferation in organoids   
encapsulated in control PEG gels and PEG hydrogels optimised with laminin 511 and 521  

















































































Figure 11. Effect of synthetic PEG optimisation with human recombinant laminin on mean 
organoid growth. (A) RNA sequencing was performed on RNA isolated from organoids after 
approximately 4 passages and the relative expression of laminin genes from 6 representative 
organoids is shown. (B) Brightfield whole well images of human intestinal organoid growth in 
synthetic PEG hydrogels optimised with 10% human recombinant laminin(s) over a 7 day 
duration at 4X magnification. Scale bar indicates 100 µM. Red dashed box indicates region of 




























intestinal organoids were embedded in 4ARM, 10K PEG hydrogels of 10% w/v that a contained 
a single, or combination, of human recombinant laminins at a 10% concentration. Data is 
expressed as the overall mean organoid growth ratio ± SE for each gel.  Statistical analysis by 
one way ANOVA with Tukey’s multiple comparison test was applied for displaying significant 
differences between laminin present and mean organoid growth ratio. *p<0.05 **P<0.01, 
***P<0.001. (D) Live and dead cells were stained with Live/dead cytotoxicity kit on day 7 of 
organoid culture in optimised hydrogels. Live cells were stained with calcein AM (green), and 
dead cells were stained with ethidium homodimer-1 (red). Images were obtained at 10 and 
20 X magnification. Scale bar is 100 µM. (E) Separately, HIOs embedded in PEG hydrogels 
optimised with a combination of human recombinant laminins or unoptimized ‘control’ PEG 
gels, were incubated independently for 3 hours withwith Edu to test for proliferation. Hoechst 
nuclear stain was utilisedutilised, and fluorescent images obtained at 40 X magnification. 





4.1 PEG based hydrogels support organoid growth and Viability  
In accordance with literature (Gjorevski et al., 2016b; Cruz-Acuña et al., 2017; Broguiere et 
al., 2018), this study demonstrates that synthetic PEG-based hydrogels can be used to 
successfully encapsulate different cell types, including more complex structures such as 
organoids. In addition, cell viability can be maintained within the gel, under normal culture 
conditions for extended periods of time. We do however, observe a distinct change in 
morphology for both tenocytes and human intestinal organoids (HIO) when encapsulated in 
PEG hydrogels. Tenocytes, which are highly mechanosensitive, do not maintain their 
elongated spindle-like structure when encapsulated in a 4 ARM, 10K PEG gel of 8% w/v. 
Instead, we observed smaller, rounded cell morphologies that were viable at both 24 hours 
and after 7 days. Similarly, for organoids encapsulated in PEG hydrogels, we do not regularly 
observe the same expansion of overall organoid size and lumen diameter, or the formation 
of budding, crypt-like domains, that are demonstrated by organoids embedded in Matrigel. 
As mechanical forces and interactions between the ECM influence cell shape and function, it 
is reasonable to assume that in an unoptimizedunoptimised PEG based hydrogel, that does 
not contain any ECM proteins and is not biologically active, cells will not interact with their 
surrounding matrix, and therefore be unable to achieve their desired morphology. However, 
as the base mechanical properties of a PEG based hydrogel supports cell and organoid viability 
for extended durations, they serve as a suitable inert substrate for optimisation through 





4.2 Tuneable mechanical properties of PEG hydrogels  
PEG is an ideal encapsulation material due to its tuneable mechanical properties, that can 
therefore be tailored, in this circumstance, to best support human intestinal organoid growth 
and development. By altering the PEG molecular weight (MW) we can alter physical 
properties of the gel, where an increase in PEG MW reduces the cross-linking density and 
therefore increases the mesh size, resulting in decreased matrix stiffness. The mesh size is the 
average distance between crosslinks within the polymer network and therefore affects the 
overall porosity of the gel. Furthermore, we can further alter the overall cross-linking density 
and gelation time by varying the final polymer content (w/v %) of the gel. We assessed 
organoid growth in a range of hydrogels constructed from PEGs of 5K-40K molecular weight 
in the w/v polymer densityconcentration range of 5-10%. We observe a large variation in 
mean organoid growth when altering the mechanical properties of the hydrogel. Markedly, a 
higher final polymer densityconcentration of 10% was seen to favour organoid growth for 
PEG gels of all MW’s. Hydrogels constructed from 10K PEG consistently and significantly 
outperformed other PEG MW gels in relation to mean organoid growth ratio at all polymer 
densitiesconcentrations, with the highest organoid growth identified in the 8 and 10% 
categories. This data suggests that human intestinal organoid growth within synthetic PEG 
hydrogels reflects the Goldilocks principle. This is to say that the overall porosity, which 
affects perfusion of media through the gel and removal of waste material, and matrix stiffness 
is at an optimal level within 10K/ 10% gels to support organoid growth. Increasing or 
decreasing the mechanical stiffness by altering the PEG MW and reducing the polymer 
content of the gel are only seen to reduce the growth potential of organoids encapsulated 
within the gel. Final polymer contents of >10% were not investigated due to the increased 
reaction rate that reduced the efficiency of organoid encapsulation.  
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Matrix stiffness of synthetic PEG hydrogels is a clear factor in regulating the growth potential 
of encapsulated HIO’s. This is due to a cells’ ability to perceive their environment through 
physical and mechanical cues such as ECM stiffness, and their ability to translate this stimuli 
into biochemical signals through mechanotransduction pathways, which then influence cell 
behaviour including growth and differentiation. How stiffness mechanosensing directly 
influences nuclear transcription activity is not wholly understood.  Recent studies have  found 
that matrix stiffness influences intestinal stem cell expansion by influencing YAP (Yes-
associated protein) activity and nuclear localization, with high matrix stiffness enhancing ISC 
survival and proliferation through a YAP-dependant mechanism (Gjorevski et al., 2016b). The 
same study also identified that in stiff matrices, the proportion of cells with nuclear YAP 
activity rapidly decrease over time, whilst organoids cultured in Matrigel maintain 
intermediate levels of nuclear YAP activity. This indicated that whilst organoid culture within 
a stiff matrix initially increases YAP activity and supports organoid growth, continued 
exposure to a stiff matrix results in compression and YAP inactivation, preventing further 
growth (Gjorevski et al., 2016b). The data produced in this study is concurrent with this 
published data, as we identified that 10K PEG, which offers increased matrix stiffness and 
therefore, predicted higher YAP activity, over 20 and 40K PEGs, provided the highest mean 
growth ratio. Increasing the stiffness further with a 5K PEG offered no growth benefit for the 
organoids and this may be due to the reduced mesh size and porosity, effecting the delivery 
of fresh nutrients to the organoids, further enforcing the Goldilocks principle.  
Recent research has also demonstrated that mechanical signals from the surrounding matrix 
can be ‘overridden’ through the inhibition of the mechanoresponsive ion channel PIEZO1, in 
order to increase proliferation and differentiation of oligodendrocyte progenitor cells in the 
ageing central nervous system, whose stem cell niche stiffens with age (Segel et al., 2019). 
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PIEZO1 is a non-selective cationic ion channel that are directly influenced by mechanical 
forces, and is expressed in mechanically active tissues, such as the gastro-intestinal 
epithelium (Alcaino, Farrugia and Beyder, 2017). The exact signalling mechanism of PIEZO1 in 
the colonic epithelium is still unknown, however, it is has been demonstrated that the piezo 
channel opens upon direct, physical deformations of the lipid bilayer, such as increased 
membrane tension and remains closed in the absence of external mechanical force (Botello-
Smith et al., 2019).  It is therefore conceivable that the stiffening of the stem cell niche may 
alter piezo 1 sensitivity and through the inhibition/activation of PIEZO1 channels expressed 
in intestinal epithelial organoids, organoid growth and proliferation can be enhanced even in 
stiffer matrices, and future research will explore this. In sum, the growth potential in the 
optimised relatively stiff PEG matrix is still reduced in relation to organoid growth in Matrigel, 
which through its susceptibility to degradation, softens over time, allowing maintenance of 
nuclear YAP activity and conceivable optimal activation of other mechanosensitive pathways 
such as PIEZO1. 
4.3 Matrix degradability and organoid growth  
We successfully demonstrate that intestinal organoid growth can be achieved in biologically 
inactive PEG, however the observable differences between organoids cultured in sub-optimal 
PEG and organoids in Matrigel, include the failure of the organoids encapsulated in PEG to 
form budding structures, and reduced expansion of organoid luminal diameter. As Matrigel is 
proteolytically degradable, and there is matrix turnover over time, we rationalised that 
organoids in Matrigel, unlike in PEG, degrade their surrounding matrix, creating sufficient 
space required to facilitate their expansion. Our data however shows that incorporating the 
proteolytically degradable VPM peptide into the synthetic PEG hydrogel backbone offered no 
benefit to the mean organoid growth ratio and failed to encourage bud formation. This was 
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despite organoids appearing more mobile within the VPM optimised PEG gels, as the overall 
position of individual organoids within the gels were seen to fluctuate more over the culture 
period (data not shown). As ECM remodelling around the physiologically intestinal crypt 
would also release sequestered growth factors such as Wnt signalling molecules and FGF 
(Chee, Virshup and Madan, 2015), we reasoned that optimising PEG hydrogel degradability 
alone in order to provide organoids with the space to grow, was not sufficient to improve 
mean organoid growth.  
4.4 ECM composition and organoid growth 
Proteomic analysis of Matrigel reveals the presence of an abundance of proteins related to 
the binding and signalling of growth factors, as well as various structural proteins (Hughes, 
Postovit and Lajoie, 2010). Although ill-defined, a prominent component of Matrigel is the 
ECM protein Laminin, including laminins 111, 121, 511 and 521 (Hughes, Postovit and Lajoie, 
2010). Considering the abundance of laminin isoforms within the ECM of the intestinal crypt, 
and the use of Matrigel as the current gold standard for intestinal organoid culture, we 
expected, as demonstrated, mean intestinal organoid growth in PEG hydrogels would be 
significantly improved by the inclusion of diluted Matrigel (5%). This result served to validate 
the approach of optimising inert synthetic PEG hydrogels and informed our decision to pursue 
the incorporation of human recombinant laminin proteins into the PEG hydrogel matrix.  
Through RNA sequencing of cultured intestinal epithelial organoids, we learned that 
organoids possess several transcripts for laminin chains including expression of LAMA5, 
LAMB1, LAMC1 (Laminin 511) and LAMA5, LAMB2, LAMC1 (Laminin 521). This would suggest 
that organoids are capable of synthesising some elements of their own ECM, in the form of 
laminin, and provides a sound rationale as to why organoids remain viable in a synthetic PEG 
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hydrogel, which is biologically inert. Furthermore, the presence of RNA transcripts for 
laminins 511 and 521 suggest a potentially vital role for these specific laminin isoforms, in the 
survival and proliferation of intestinal organoids. Interestingly, the same combination of 
laminins (511 and 521) are also expressed at significantly high levels in Matrigel (Hughes, 
Postovit and Lajoie, 2010) furthering the notion that these specific isoforms are uniquely 
responsible for organoid development. Not surprisingly, organoids cultured in PEG hydrogels 
that were supplemented with a combination of laminin 511 and 521, possessed a significantly 
increased mean organoid growth ratio when compared to control. This increase is also 
significantly different from hydrogels that possessed laminin 521 in isolation, suggesting a 
potentially additive effect in the mechanism of action by which these laminins confer 
improved cell proliferation.  
4.5 Potential of PEG hydrogels for further optimisation  
Although intestinal organoids embedded in PEG hydrogels optimised with human laminin 511 
and 521 display improved growth characteristics, there remains a distinct and regular absence 
of budding, crypt-like domains, that is characteristic of organoid development under optimal 
conditions. This would suggest that although laminins are an important ECM element whose 
inclusion enhances organoid growth, they are not the sole contribution to optimal organoid 
architecture. An aforementioned study suggests the importance of a mechanically dynamic 
matrix that begins with high stiffness, but softens over time (Gjorevski et al., 2016b). This 
highlights the necessity to incorporate multiple areas of optimisation, namely both biological 
matrix composition, and degradability, into a single hydrogel. By rendering a PEG based 
hydrogel mechanically dynamic through VPM incorporation, as well as incorporating the 
adhesive properties of biologically relevant laminins, it is conceivable that organoids will 
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create the space they need to expand whilst interacting with the surrounding matrix, 
prompting the formation of budding structures.  
Furthermore, as our data suggests that laminins are not capable of solely replicating the 
organoid growth that is demonstrated in Matrigel, it is necessary to explore other elements 
of optimisation. Heparan sulfate (HS) proteoglycans are complex molecules consisting of one 
or more HS chain bound covalently to a protein backbone, and are distributed throughout the 
ECM as well as being present on many cell surfaces (Vicente et al., 2018). Membrane bound 
HS proteoglycans have been known to co-operate with cell adhesion receptors such as 
integrins, and help facilitate cell-ECM interactions (Kim, Turnbull and Guimond, 2011). HS 
proteoglycans also serve as a ligand for CD44, a family of cell adhesion and signalling 
molecules that have effects on proliferation and survival, and in the intestinal mucosa, serves 
as an intestinal stem cell marker and direct target of Wnt signalling (Zeilstra et al., 2013). We 
would hypothesise that the inclusion of HS proteoglycans into the synthetic PEG matrix would 
further aid in organoid growth and the formation of budding structures, and can be used in 
combination with laminins and the degradable peptide to create a highly optimised and 
defined matrix that specifically supports the growth of human intestinal organoids.  
4.6 Limitations of study and Future Research  
 
In progressing with this research, it would be necessary to combine the functional data of 
organoid growth from altering the PEG molecular weight and polymer densityconcentration, 
with rheological data for each gel, as there appears to be a narrow physiological window at 
which mechanical stiffness best supports organoid formation and development. It is 
necessary to quantify this stiffness, allowing for better comparisons to be drawn between 
individual optimised PEG gels, and other matrices such as Matrigel.  Furthermore, as we wish 
Formatted: Font: 12 pt, Italic, Font color: Auto
Formatted: Heading 2, Left, Line spacing:  single
Formatted: Font: 12 pt, Italic
56 
 
to explore the effect of interfering with mechanostransduction pathways and mechano-
sensitive ion channels has in relation to organoid growth in matrices of varying stiffness, it is 
important to fully quantify hydrogel properties at a rheological level.  
In addition, it would be necessary to expand the methodology of obtaining organoid growth 
data. Taking measurements of cross sectional area in one plane of focus across multiple time 
points, although providing a consistent point of comparison, does not account for the 
complexity of 3D organoid structures, or organoid growth that may be occurring across 
different dimensions. It would perhaps be more beneficial to use more advanced, high 
resolution, confocal live cell-microscopy in order to more accurately assess the growth of 3D 
organoids. This can be coupled with fluorescent labelling to visualise different cellular 
processes as well as overall tissue architecture.  
Another potential area for further analysis is the swelling characteristics of PEG hydrogels. 
Hydrogel swelling is the amount of water or buffer taken up by the hydrogel and can indicate 
the hydrophilicity of the polymer network, as well as crosslinking density, where stiffer 
networks exhibit less swelling (Caliari and Burdick, 2016). Hydrogel swelling, which is likely to 
occur when organoids within the hydrogel are flooded with media, will have an effect on the 
gels microstructure and mechanical properties such as mesh size. Concentrations of PEG can 
be expressed as a molarity and this can be used to compare swelling ratios of hydrogels 
comprised of different molecular weight PEGs. This will allow for a more comprehensive 
comparison between hydrogels and can provide rational behind the performance of different 
PEG hydrogels.  
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4.76 Concluding remarks  
In this study, summarised in figure 12,  we demonstrate the ability of synthetic, 
unoptimizedunoptimised PEG based hydrogels to support human intestinal organoid growth 
and viability under normal culture conditions. To further this, we begin to explore the 
versatility in the optimising potential that is offered by PEG hydrogels, through the alteration 
of matrix stiffness by using PEGs of increasing molecular weight as well as altering the , 
polymer densityconcentration within hydrogels. Furthermore we assess how , hydrogel 
degradability influences organoid growth and morphology through the inclusion of a 
degradable peptide, and we explore how and adhesive ligand presentation through the 
incorporation of low concentrations of Matrigel and human derived laminin influence 
organoid growth, morphology and survival. These data in combination, highlight the 
possibility by which the animal derived natural matrix of Matrigel, can be replaced by fully 
optimised, synthetic, PEG based hydrogels that are tailored specifically to the growth of 

























Figure 12.  Summary schematic highlighting the different tuneable properties of PEG 
hydrogels that can be relevant for human intestinal organoid growth (blue squares). Each 
category contains the properties altered and tested in this body of work (orange circle) and 
the effects or potential effects that altering these properties will have are also highlighted 
(green rectangle). Properties not directly tested, but of potential biological relevance that 
future work will hope to explore is also depicted (red triangle)  
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Supplementary Table 1. Statistical data for one-way ANOVA applied for the variables of 
organoid growth in response to polymer densityconcentration/PEG molecular weight 
combination. N = the number of individual culture replicates, n = number of organoids 
analysed.  
Gel N n ANOVA   
10% 8% 6.40% 5% P 
5K small 2 8 11 8 9 <0.001 
5K large 2 8 6 6 5 <0.001 
10K small 2 13 15 12 15 <0.001 
10K large 2 7 9 4 5 0.008 
20K small 2 11 11 8 9 0.004 
20K large 2 11 8 11 11 0.022 
40K small 1 9 11 5 5 0.864 
40K large 1 10 7 4 4 0.685 
 
Supplementary Table 2. Statistical data for one-way ANOVA applied for the variables of 
organoid growth in response to Matrigel concentration. N = the number of individual culture 
replicates, n = number of organoids analysed. 
Gel N n ANOVA   
10% 5% 2.50% control P 
8% PEG + Matrigel 
small 
2 9 9 8 9 0.029 
8% PEG + Matrigel 
large 
2 6 7 8 6 0.004 
10% PEG + Matrigel 
small 
2 18 16 17 17 0.024 
10% PEG + Matrigel 
large 






Supplementary Table 3. Statistical data for one-way ANOVA applied for the variables of 
organoid growth in response to VPM:PEG ratio. N = the number of individual culture 
replicates, n = number of organoids analysed. 
Gel N n ANOVA 
  
Control 02:01 01:01 P 
PEG + VPM small 2 18 22 24 <0.001 
PEG + VPM large 2 16 22 13 0.391 
 
Supplementary Table 4. Statistical data for one-way ANOVA applied for the variables of 
organoid growth in response to laminin type. N = the number of individual culture replicates, 
n = number of organoids analysed. 
Gel N n ANOVA 
  
Control 111 121 511 521 511+521 All P 









6. List of Abbreviations  
ISC Intestinal stem cell 
CBC Crypt base columnar 
EGF Epidermal growth factor 
TGF alpha Transforming growth factor alpha 
CF Cystic fibrosis 
cAMP Cyclic adenosine monophosphate 
CFTR Cystic fibrosis transmembrane conductance regulator 
APC Adenomatous polyposis coli 
Tcf4 Transcription factor 4 
LGR5 Leucine-rich repeat-containing G-protein coupled receptor 5 
IBD Inflammatory bowel disease 
3D Three-dimensional 
ECM Extracellular matrix 
PG Proteoglycan 
FGF Fibroblast growth factors 
VEGF Vascular endothelial growth factor 
MMP Matrix metalloprotease 
PEG Polyethylene glycol 
VS Vinyl sulfone 
SH Thiol 
MAL Maleimide 
GFP Green fluorescent protein 
DMEM Dulbecco's Modified Eagle Media 
P-strep Penecillin-streptomycin 
PBS Phosphate buffered saline 
EDTA Ethylenediaminetetraacetic acid 
HBS Hepes buffered saline 
NNUH Norfolk and Norwich University Hospital 
NHS National Health Service 
hCCCM Human colonic crypt culture media 
w/v Weight by volume 
DIC Differential interface contrast 
CSA Cross sectional area 
EdU 5-ethynyl-2'-deoxyuridine 
SDS Sodium dodecyl sulfate 
BSA Bovine serum albumin 
IgG Immunoglobulin G 
RNA Ribonucleic acid 
DNA Deoxyribonucleic acid 
HIO Human intestinal organoid 
MW Molecular weight 
YAP Yes-associated protein 
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